BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30063751)

  • 1. Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD.
    Alisi A; Pampanini V; De Stefanis C; Panera N; Deodati A; Nobili V; Cianfarani S
    PLoS One; 2018; 13(7):e0201566. PubMed ID: 30063751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease.
    Chishima S; Kogiso T; Matsushita N; Hashimoto E; Tokushige K
    Intern Med; 2017; 56(5):473-480. PubMed ID: 28250290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I and -II levels are associated with the progression of nonalcoholic fatty liver disease in obese children.
    Cianfarani S; Inzaghi E; Alisi A; Germani D; Puglianiello A; Nobili V
    J Pediatr; 2014 Jul; 165(1):92-8. PubMed ID: 24607243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of IGF-1 receptor and GH receptor in hepatic tissue of patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Osganian SA; Subudhi S; Masia R; Drescher HK; Bartsch LM; Chicote ML; Chung RT; Gee DW; Witkowski ER; Bredella MA; Lauer GM; Corey KE; Dichtel LE
    Growth Horm IGF Res; 2022 Aug; 65():101482. PubMed ID: 35780715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver.
    Takahashi Y
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Analysis of Three Hormonal Systems Identifies Molecules Associated with the Presence and Severity of NAFLD.
    Polyzos SA; Perakakis N; Boutari C; Kountouras J; Ghaly W; Anastasilakis AD; Karagiannis A; Mantzoros CS
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e390-400. PubMed ID: 31690932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-1 mRNA isoforms and insulin-like growth factor-1 receptor mRNA expression in chronic hepatitis C.
    Kasprzak A; Adamek A; Przybyszewska W; Pyda P; Szmeja J; Seraszek-Jaros A; Lanzafame A; Surdacka A; Mozer-Lisewska I; Koczorowska M
    World J Gastroenterol; 2015 Apr; 21(13):3867-75. PubMed ID: 25852271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor 1 and metabolic parameters are associated with nonalcoholic fatty liver disease in obese children and adolescents.
    Liang S; Cheng X; Hu Y; Song R; Li G
    Acta Paediatr; 2017 Feb; 106(2):298-303. PubMed ID: 27889912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
    Li BH; He FP; Yang X; Chen YW; Fan JG
    Transl Res; 2017 Feb; 180():103-117.e4. PubMed ID: 27639593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.
    Mansoor S; Yerian L; Kohli R; Xanthakos S; Angulo P; Ling S; Lopez R; Christine CK; Feldstein AE; Alkhouri N
    Dig Dis Sci; 2015 May; 60(5):1440-7. PubMed ID: 25540086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
    Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
    Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma Cytokeratin-18 Level As a Novel Biomarker for Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
    Mandelia C; Collyer E; Mansoor S; Lopez R; Lappe S; Nobili V; Alkhouri N
    J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):181-7. PubMed ID: 26835904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of human insulin-like growth factor-1 and levels of insulin-like growth factor-binding protein-5 in patients with nonalcoholic fatty liver disease: association with liver histology.
    Colak Y; Senates E; Ozturk O; Yilmaz Y; Zemheri E; Yilmaz Enc F; Ulasoglu C; Aksaray S; Bozbeyoglu SG; Kiziltas S; Kurdas OO; Tuncer I
    Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):255-61. PubMed ID: 22157234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-I induces senescence of hepatic stellate cells and limits fibrosis in a p53-dependent manner.
    Nishizawa H; Iguchi G; Fukuoka H; Takahashi M; Suda K; Bando H; Matsumoto R; Yoshida K; Odake Y; Ogawa W; Takahashi Y
    Sci Rep; 2016 Oct; 6():34605. PubMed ID: 27721459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic Sleeve Gastrectomy Improves Nonalcoholic Fatty Liver Disease-Related Liver Damage in Adolescents by Reshaping Cellular Interactions and Hepatic Adipocytokine Production.
    Nobili V; Carpino G; De Peppo F; Caccamo R; Mosca A; Romito I; Overi D; Franchitto A; Onori P; Alisi A; Gaudio E
    J Pediatr; 2018 Mar; 194():100-108.e3. PubMed ID: 29198531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
    Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
    Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study.
    Hagström H; Stål P; Hultcrantz R; Brismar K; Ansurudeen I
    Scand J Gastroenterol; 2017 Dec; 52(12):1427-1434. PubMed ID: 28927302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Han MH; Lee JH; Kim G; Lee E; Lee YR; Jang SY; Lee HW; Chun JM; Han YS; Yoon JS; Kang MK; Lee WK; Kweon YO; Tak WY; Park SY; Park JG; Hur K
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32413995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.